Skip to main content
Erschienen in: Rheumatology International 7/2013

01.07.2013 | Original Article

Comparison of PA spine, lateral spine, and femoral BMD measurements to determine bone loss in ankylosing spondylitis

verfasst von: Mehmet Ali Ulu, Remzi Çevik, Banu Dilek

Erschienen in: Rheumatology International | Ausgabe 7/2013

Einloggen, um Zugang zu erhalten

Abstract

To evaluate bone loss in the early- and late-stage ankylosing spondylitis (AS) patients using posteroanterior (PA) and lateral lumbar and femoral bone mineral density (BMD) measurement methods. Eighty-six AS patients and 50 control subjects were enrolled. PA spine, lateral spine, and femur BMD values of patients and controls were measured. The presence of any syndesmophytes or compression fractures was determined. Patients were divided as early (<10 years) and late stage (≥10 years) according to the onset of the inflammatory pain. Mean PA spinal BMD was similar in patients and controls (p = 0.460). Femoral and lateral spine BMD values were significantly lower in patients (p = 0.012 and p = 0.001). When comparing early- and late-stage AS groups, mean PA spinal BMD was found to be lower in the early group (p = 0.005), while femoral and lateral spinal values were lower (although statistically not significant) in the late group. At least one compression fracture was present in 28 % of patients. Although not statistically significant, mean PA spinal BMD was higher in those with fractures. Femoral and lateral spinal BMD values were significantly lower in the fracture group (p = 0.034 and p = 0.004). Lateral spinal BMD values were significantly lower in patients with syndesmophytes (p = 0.004). Bone loss is increased in AS compared with control subjects. The BMD measurement at the lateral lumbar spine reflects bone loss and fracture risk better than PA spine and femoral measurements.
Literatur
1.
Zurück zum Zitat El Maghraou A, Borderie D, Cherruau B, Edouard R, Roux C, Dougados M (1999) Osteoporosis, body composition, and bone turnover in ankylosing spondylitis. J Rheumatol 26:2205–2209 El Maghraou A, Borderie D, Cherruau B, Edouard R, Roux C, Dougados M (1999) Osteoporosis, body composition, and bone turnover in ankylosing spondylitis. J Rheumatol 26:2205–2209
2.
Zurück zum Zitat Hanson CA, Shagrin JW, Duncan H (1971) Vertebral osteoporosis in ankylosing spondylitis. Clin Orthop Rel Res 74:59–64 Hanson CA, Shagrin JW, Duncan H (1971) Vertebral osteoporosis in ankylosing spondylitis. Clin Orthop Rel Res 74:59–64
3.
Zurück zum Zitat Mitra D, Elvins DM, Speden DJ, Collins AJ (2000) The prevalence of vertebral fractures in mild ankylosing spondylitis and their relationship to bone mineral density. Rheumatology 39:85–89PubMedCrossRef Mitra D, Elvins DM, Speden DJ, Collins AJ (2000) The prevalence of vertebral fractures in mild ankylosing spondylitis and their relationship to bone mineral density. Rheumatology 39:85–89PubMedCrossRef
4.
Zurück zum Zitat Will R, Palmer R, Bhalla AK, Ring F, Calin A (1989) Osteoporosis in early ankylosing spondylitis: a primary pathological event? Lancet 2:1483–1485PubMedCrossRef Will R, Palmer R, Bhalla AK, Ring F, Calin A (1989) Osteoporosis in early ankylosing spondylitis: a primary pathological event? Lancet 2:1483–1485PubMedCrossRef
5.
Zurück zum Zitat O’Neill TW, Felsenberg D, Varlow J, Cooper C, Kanis JA, Silman AJ (1996) The prevalence of vertebral deformity in European men and women: the European Vertebral Osteoporosis Study. J Bone Miner Res 11:1010–1018PubMedCrossRef O’Neill TW, Felsenberg D, Varlow J, Cooper C, Kanis JA, Silman AJ (1996) The prevalence of vertebral deformity in European men and women: the European Vertebral Osteoporosis Study. J Bone Miner Res 11:1010–1018PubMedCrossRef
6.
Zurück zum Zitat Reid DM, Nicoll JJ, Kenedy NS, Smith MA, Tothill P, Nuki G (1986) Bone mass in ankylosing spondylitis. J Rheumatol 13:932–935PubMed Reid DM, Nicoll JJ, Kenedy NS, Smith MA, Tothill P, Nuki G (1986) Bone mass in ankylosing spondylitis. J Rheumatol 13:932–935PubMed
7.
Zurück zum Zitat Cooper C, Carbone L, Michet CJ, Atkinson EJ, O’Fallon W, Melton L (1994) Fracture risk in patients with ankylosing spondylitis: a population-based study. J Rheumatol 21:1877–1882PubMed Cooper C, Carbone L, Michet CJ, Atkinson EJ, O’Fallon W, Melton L (1994) Fracture risk in patients with ankylosing spondylitis: a population-based study. J Rheumatol 21:1877–1882PubMed
8.
Zurück zum Zitat Devogelaer J-P, Dufour J, Huaux L, Deuxchaisnes C (1984) Appendicular and spinal bone mass in ankylosing spondylitis. Clin Rhematol 3:105 Devogelaer J-P, Dufour J, Huaux L, Deuxchaisnes C (1984) Appendicular and spinal bone mass in ankylosing spondylitis. Clin Rhematol 3:105
9.
Zurück zum Zitat Mullaji AB, Upadhyay SS, Ho EK (1994) Bone mineral density in ankylosing spondylitis. DEXA comparison of control subjects with mild and advanced cases. J Bone Joint Surg Br 76:660–665PubMed Mullaji AB, Upadhyay SS, Ho EK (1994) Bone mineral density in ankylosing spondylitis. DEXA comparison of control subjects with mild and advanced cases. J Bone Joint Surg Br 76:660–665PubMed
10.
Zurück zum Zitat Rubenstein H (1991) Osteoporosis in ankylosing spondylitis. Br J Rheumatol 30:160CrossRef Rubenstein H (1991) Osteoporosis in ankylosing spondylitis. Br J Rheumatol 30:160CrossRef
11.
Zurück zum Zitat Calin A (1991) Osteoporosis and ankylosing spondylitis. Br J Rheumatol 30:318–319 Calin A (1991) Osteoporosis and ankylosing spondylitis. Br J Rheumatol 30:318–319
12.
Zurück zum Zitat Mitra D, Elvins DM, Collins AJ (1999) Testesterone and TFI in mild ankylosing spondylitis. J Rheumatol 26:2414–2417PubMed Mitra D, Elvins DM, Collins AJ (1999) Testesterone and TFI in mild ankylosing spondylitis. J Rheumatol 26:2414–2417PubMed
13.
Zurück zum Zitat Franck H, Meurer T, Lorenz CH (2004) Evaluation of bone mineral density, hormones, biochemical markers of bone metabolism, and osteoprotegerin serum levels in patients with ankylosing spondylitis. J Rheumatol 31:2236–2241PubMed Franck H, Meurer T, Lorenz CH (2004) Evaluation of bone mineral density, hormones, biochemical markers of bone metabolism, and osteoprotegerin serum levels in patients with ankylosing spondylitis. J Rheumatol 31:2236–2241PubMed
14.
Zurück zum Zitat Spencer DG, Park WM, Dick HM, Papazoglu SN, Buchanan WW (1979) Radiological manifestations in 200 patients with ankylosing spondylitis: correlation with clinical features and HLA B27. J Rheumatol 6:305–315PubMed Spencer DG, Park WM, Dick HM, Papazoglu SN, Buchanan WW (1979) Radiological manifestations in 200 patients with ankylosing spondylitis: correlation with clinical features and HLA B27. J Rheumatol 6:305–315PubMed
15.
Zurück zum Zitat Bessant R, Keat A (2002) How should clinicians manage osteoporosis in ankylosing spondylitis. J Rheumatol 29:1511–1519PubMed Bessant R, Keat A (2002) How should clinicians manage osteoporosis in ankylosing spondylitis. J Rheumatol 29:1511–1519PubMed
16.
Zurück zum Zitat Bronson WD, Walker SE, Hilman LS, Keisler D, Hoyt T, Allen SH (1998) Bone mineral density and biochemical markers of bone metabolism in ankylosing spondylitis. J Rhematol 25:929–935 Bronson WD, Walker SE, Hilman LS, Keisler D, Hoyt T, Allen SH (1998) Bone mineral density and biochemical markers of bone metabolism in ankylosing spondylitis. J Rhematol 25:929–935
17.
Zurück zum Zitat Donnelly S, Doyle DV, Denton A, Rolfe I, McCloskey EV, Spector TD (1994) Bone mineral density and vertebral compression fracture rates in ankylosing spondylitis. Ann Rheum Dis 53:117–121PubMedCrossRef Donnelly S, Doyle DV, Denton A, Rolfe I, McCloskey EV, Spector TD (1994) Bone mineral density and vertebral compression fracture rates in ankylosing spondylitis. Ann Rheum Dis 53:117–121PubMedCrossRef
18.
Zurück zum Zitat Singh A, Bronson W, Walker SE, Allen SH (1995) Relative value of femoral and lumbar bone mineral density assesments in patients with ankylosing spondylitis. South Med J 88:939–943PubMedCrossRef Singh A, Bronson W, Walker SE, Allen SH (1995) Relative value of femoral and lumbar bone mineral density assesments in patients with ankylosing spondylitis. South Med J 88:939–943PubMedCrossRef
19.
Zurück zum Zitat Will R, Palmer R, Bhalla AK, Ring F, Calin A (1990) Bone loss as well as bone formation is a feature of progressive ankylosing spondylitis. Br J Rheumatol 29(6):498–499PubMedCrossRef Will R, Palmer R, Bhalla AK, Ring F, Calin A (1990) Bone loss as well as bone formation is a feature of progressive ankylosing spondylitis. Br J Rheumatol 29(6):498–499PubMedCrossRef
20.
Zurück zum Zitat Masud T, Langley S, Wiltshire P, Doyle D, Spector T (1993) Effect of spinal osteophytosis on bone mineral density measurements in vertebral osteoporosis. BMJ 307:172–173PubMedCrossRef Masud T, Langley S, Wiltshire P, Doyle D, Spector T (1993) Effect of spinal osteophytosis on bone mineral density measurements in vertebral osteoporosis. BMJ 307:172–173PubMedCrossRef
21.
Zurück zum Zitat Gılgıl E, Kacar C, Tuncer T, Butun B (2005) The association of syndesmophytes with vertebral bone mineral density in patients with ankylosing spondylitis. J Rheumatol 32:292–294PubMed Gılgıl E, Kacar C, Tuncer T, Butun B (2005) The association of syndesmophytes with vertebral bone mineral density in patients with ankylosing spondylitis. J Rheumatol 32:292–294PubMed
22.
Zurück zum Zitat Muntean L, Rojas-Vargas M, Font P, Simon SP, Rednic S, Schiotis R (2011) Relative value of the lumbar spine and hip bone mineral density and bone turnover markers in men with ankylosing spondylitis. Clin Rheumatol 30:691–695PubMedCrossRef Muntean L, Rojas-Vargas M, Font P, Simon SP, Rednic S, Schiotis R (2011) Relative value of the lumbar spine and hip bone mineral density and bone turnover markers in men with ankylosing spondylitis. Clin Rheumatol 30:691–695PubMedCrossRef
23.
Zurück zum Zitat Yu W, Glüer C-C, Fuerst T, Grampp S, Li J, Lu Y et al (1995) Influence of degenerative joint disease on spinal bone mineral measurements in postmenopausal women. Calcif Tissue Int 57:169–174PubMedCrossRef Yu W, Glüer C-C, Fuerst T, Grampp S, Li J, Lu Y et al (1995) Influence of degenerative joint disease on spinal bone mineral measurements in postmenopausal women. Calcif Tissue Int 57:169–174PubMedCrossRef
24.
Zurück zum Zitat Reid IR, Evans MC, Stapleton J (1992) Lateral spine densitometry is a more sensitive indicator of glucocorticoid-induced bone loss. J Bone Miner Res 7:1221–1225PubMedCrossRef Reid IR, Evans MC, Stapleton J (1992) Lateral spine densitometry is a more sensitive indicator of glucocorticoid-induced bone loss. J Bone Miner Res 7:1221–1225PubMedCrossRef
25.
Zurück zum Zitat Karberg K, Zochling J, Sieper J, Felsenberg D, Braun JL (2005) Bone loss is detected more frequently in patients with ankylosing spondylitis with syndesmophytes. J Rheumatol 32:1290–1298PubMed Karberg K, Zochling J, Sieper J, Felsenberg D, Braun JL (2005) Bone loss is detected more frequently in patients with ankylosing spondylitis with syndesmophytes. J Rheumatol 32:1290–1298PubMed
26.
Zurück zum Zitat Bessant R, Harris C, Keat A (2003) Audit of the diagnosis, assessment, and treatment of osteoporosis in patients with ankylosing spondylitis. J Rheumatol 30:779–782PubMed Bessant R, Harris C, Keat A (2003) Audit of the diagnosis, assessment, and treatment of osteoporosis in patients with ankylosing spondylitis. J Rheumatol 30:779–782PubMed
27.
Zurück zum Zitat Wendling D (2005) Bone loss in ankylosing spondylitis: can we put the puzzle together? J Rheumatol 32:1184–1185PubMed Wendling D (2005) Bone loss in ankylosing spondylitis: can we put the puzzle together? J Rheumatol 32:1184–1185PubMed
28.
Zurück zum Zitat Meirelles ES, Borelli A, Camargo OP (1999) Influence of disease activity and chronicity on ankylosing spondylitis bone mass loss. Clin Rheumatol 18:364–368PubMedCrossRef Meirelles ES, Borelli A, Camargo OP (1999) Influence of disease activity and chronicity on ankylosing spondylitis bone mass loss. Clin Rheumatol 18:364–368PubMedCrossRef
29.
Zurück zum Zitat Başkan BM, Doğan YP, Sivas F, Bodur H, Özoran K (2010) The relation between osteoporosis and vitamin D levels and disease activity in ankylosing spondylitis. Rheumatol Int 30:375–381CrossRef Başkan BM, Doğan YP, Sivas F, Bodur H, Özoran K (2010) The relation between osteoporosis and vitamin D levels and disease activity in ankylosing spondylitis. Rheumatol Int 30:375–381CrossRef
30.
Zurück zum Zitat Ghozlani I, Ghazi M, Nouijai A, Mounach A, Rezqi A, Achemlal L (2009) Prevalence and risk factors of osteoporosis and vertebral fractures in patients with ankylosing spondylitis. Bone 44:772–776PubMedCrossRef Ghozlani I, Ghazi M, Nouijai A, Mounach A, Rezqi A, Achemlal L (2009) Prevalence and risk factors of osteoporosis and vertebral fractures in patients with ankylosing spondylitis. Bone 44:772–776PubMedCrossRef
31.
Zurück zum Zitat Borman P, Bodur H, Bingöl N, Bingöl S, Bostan E (2001) Bone mineral density and bone turnover markers in a group of male ankylosing spondylitis patients: relationship to disease activity. J Clin Rheumatol 7:315–321PubMedCrossRef Borman P, Bodur H, Bingöl N, Bingöl S, Bostan E (2001) Bone mineral density and bone turnover markers in a group of male ankylosing spondylitis patients: relationship to disease activity. J Clin Rheumatol 7:315–321PubMedCrossRef
Metadaten
Titel
Comparison of PA spine, lateral spine, and femoral BMD measurements to determine bone loss in ankylosing spondylitis
verfasst von
Mehmet Ali Ulu
Remzi Çevik
Banu Dilek
Publikationsdatum
01.07.2013
Verlag
Springer-Verlag
Erschienen in
Rheumatology International / Ausgabe 7/2013
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-012-2632-9

Weitere Artikel der Ausgabe 7/2013

Rheumatology International 7/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.